The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Market Overview

The COVID-19 saliva screening test market has shown significant growth, expanding from $3.57 billion in 2023 to an expected $3.90 billion in 2024, reflecting a compound annual growth rate (CAGR) of 9.3%. This robust growth is driven by:

• Potential for home testing
• Unprecedented need for diagnostic testing
• Increased public awareness
• Investment in research and development

Future Market Projections

The market is anticipated to continue its upward trajectory, reaching $5.64 billion by 2028 with a CAGR of 9.6%. Key factors contributing to this growth include:

• Integration with screening programs
• Regulatory support
• Growing demand for speedy, point-of-care tests
• Increasing population
• Rise of e-commerce

Major Trends

• Increased adoption in non-healthcare settings
• Integration with digital health platforms
• Emergence of next-generation technologies
• Technological advancements
• Strategic partnerships

View More On The COVID-19 Saliva Screening Test Potential Market Report 2024 – https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Impact of Healthcare Expenditure

Increasing healthcare expenditure is a significant driver of market growth. Factors contributing to higher healthcare spending include:

• Minimally invasive surgeries
• Cutting-edge diagnostic tools
• Increased R&D for new drugs
• Greater utilization of healthcare services
• Specialty medications

Example

In the UK, healthcare expenditure grew by 9.7% in real terms and 9.4% in nominal terms in 2021. This included a substantial increase in spending on pharmaceuticals and preventative care, highlighting the importance of resource allocation in pandemic management and public health outcomes.

Key Players in the Market

Several major companies dominate the COVID-19 saliva screening test market:

• Roche Diagnostics Corporation
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Becton Dickinson and Company
• Danaher Corporation
• Hologic Inc.
• PerkinElmer Inc.
• Quidel Corporation
• Cepheid
• Seegene Inc.

Innovative Technologies and Programs

Innovation is a cornerstone of market growth, with companies developing advanced testing programs to meet rising demand. For instance:

Mount Sinai Health System

In April 2021, Mount Sinai Health System launched a COVID-19 PCR Saliva Testing program. Key features of this program include:

• Quick, noninvasive, and precise testing
• Scalability to process up to 100,000 daily tests
• Results within 24 hours for most tests
• Child-friendly and comfortable testing options

Strategic Acquisitions

Strategic acquisitions are bolstering market presence and expanding capabilities:

Hologic Inc. and Mobidiag Oy

In June 2021, Hologic Inc. acquired Mobidiag Oy, enhancing its diagnostics market presence with innovative near-patient molecular diagnostic instruments and tests. This acquisition highlights the strategic moves companies are making to stay competitive and expand their product offerings.

Market Segmentation

The COVID-19 saliva screening test market is segmented by:

Location

• Travel Stations
• Sports Arenas
• Entertainment Venues
• Corporate Campus Environments
• Universities and Colleges
• Factories
• Other Locations

Technology

• Fluorescence-Labelled Antigen
• RT-PCR
• CRISPR-Cas9

Mode of Testing

• Centralized Testing
• Decentralized Testing

Regional Insights

North America was the largest region in the COVID-19 saliva screening test market in 2023, driven by strong healthcare infrastructure, regulatory support, and high public awareness.

The continuous advancements and strategic initiatives in the COVID-19 saliva screening test market underscore its critical role in pandemic management and public health. As the market evolves, it will play a pivotal role in shaping the future of diagnostic testing and healthcare delivery.

Request A Sample Of The Global COVID-19 Saliva Screening Test Potential Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16026&type=smp